These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 10974369

  • 1. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
    Smee DF, Bailey KW, Wong M, Sidwell RW.
    Antiviral Res; 2000 Sep; 47(3):171-7. PubMed ID: 10974369
    [Abstract] [Full Text] [Related]

  • 2. Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
    Smee DF, Bailey KW, Sidwell RW.
    Antivir Chem Chemother; 2000 Jul; 11(4):303-9. PubMed ID: 10950392
    [Abstract] [Full Text] [Related]

  • 3. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
    Smee DF, Bailey KW, Sidwell RW.
    Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
    [Abstract] [Full Text] [Related]

  • 4. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
    Smee DF, Bailey KW, Wong MH, Sidwell RW.
    Antiviral Res; 2001 Oct; 52(1):55-62. PubMed ID: 11530188
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
    Smee DF, Bailey KW, Sidwell RW.
    Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
    [Abstract] [Full Text] [Related]

  • 6. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge.
    Roy CJ, Baker R, Washburn K, Bray M.
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2933-7. PubMed ID: 12936997
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
    Quenelle DC, Collins DJ, Kern ER.
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
    [Abstract] [Full Text] [Related]

  • 8. Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
    Smee DF, Gowen BB, Wandersee MK, Wong MH, Skirpstunas RT, Baldwin TJ, Hoopes JD, Sidwell RW.
    Int J Antimicrob Agents; 2008 Apr; 31(4):352-9. PubMed ID: 18206353
    [Abstract] [Full Text] [Related]

  • 9. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
    Quenelle DC, Collins DJ, Wan WB, Beadle JR, Hostetler KY, Kern ER.
    Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
    [Abstract] [Full Text] [Related]

  • 10. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF, Sidwell RW, Kefauver D, Bray M, Huggins JW.
    Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
    [Abstract] [Full Text] [Related]

  • 11. Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.
    Bray M, Martinez M, Kefauver D, West M, Roy C.
    Antiviral Res; 2002 Jun; 54(3):129-42. PubMed ID: 12062386
    [Abstract] [Full Text] [Related]

  • 12. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
    Smee DF, Bailey KW, Sidwell RW.
    Antivir Chem Chemother; 2001 Jan; 12(1):71-6. PubMed ID: 11437324
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo imaging of cidofovir treatment of cowpox virus infection.
    Goff A, Twenhafel N, Garrison A, Mucker E, Lawler J, Paragas J.
    Virus Res; 2007 Sep; 128(1-2):88-98. PubMed ID: 17524511
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
    Smee DF, Wong MH, Bailey KW, Beadle JR, Hostetler KY, Sidwell RW.
    Int J Antimicrob Agents; 2004 May; 23(5):430-7. PubMed ID: 15120719
    [Abstract] [Full Text] [Related]

  • 17. Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice.
    Smee DF, Wandersee MK, Bailey KW, Wong MH, Chu CK, Gadthula S, Sidwell RW.
    Antiviral Res; 2007 Jan; 73(1):69-77. PubMed ID: 16712967
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro.
    Keith KA, Wan WB, Ciesla SL, Beadle JR, Hostetler KY, Kern ER.
    Antimicrob Agents Chemother; 2004 May; 48(5):1869-71. PubMed ID: 15105146
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.